Latest Utilities News

Vanadium Resources has secured an oversubscribed A$1.0 million placement to advance studies, site work, offtake discussions and project financing for its planned V-Iron Plant in South Africa. The raise gives VR8 fresh development capital, but the project still depends on a scoping study, binding commercial agreements and a much larger funding package.

Andromeda Metals has secured $3.04 million through a Share Purchase Plan and placement, aiming to advance its High Purity Alumina project and complete a Pre-feasibility study.

Vanadium Resources (ASX: VR8) has locked in a right of first refusal and exclusivity option over a prime brownfield site in South Africa’s Highveld Industrial Park for its planned V-Iron Plant, reinforcing its path towards feasibility and financing.

Imricor Medical Systems has reached a crucial milestone as the FDA accepts and closes the manufacturing module of its Premarket Approval submission, advancing its MR-guided electrophysiology devices closer to US market entry.

Artrya has launched its AI-powered Salix® platform commercially in the US, securing three foundation health systems and raising $80 million to fuel growth. With FDA clearance for its Coronary Plaque module and a pivotal clinical study underway, the company is poised for scaling revenues amid a strong balance sheet.

Optiscan Imaging has launched a 35-patient clinical trial in the US to test its InVue™ and InForm™ platforms in head and neck cancer surgery, aiming to bolster its FDA submissions later this year.

Etherstack has agreed to an expanded scope on its key UK government project, adding £0.5 million (US$0.7 million) in revenue and lifting ongoing support fees, with positive impact expected in H1 FY27.

Barton Gold has reported significant high-grade gold mineralisation from its Phase 2 drilling at the Tunkillia Gold Project, potentially boosting resource grades and project economics ahead of a Pre-feasibility Study targeted for early 2027.

Island Pharmaceuticals has obtained regulatory rights to reference critical Marburg-Angola virus natural history data, clearing a significant FDA hurdle for its antiviral Galidesivir. This milestone accelerates the path toward pivotal animal studies and potential FDA approval under the Animal Rule.

Tanami Gold’s Central Tanami Project Joint Venture has inked a $38 million contract with Macmahon to build a 3.5km underground decline, setting the stage for a major resource upgrade and development decision in 2027.

MGX Resources and Tanami Gold have contracted Macmahon Underground for a $38 million build of a 3.5km underground decline at Groundrush, aiming to upgrade 400,000 ounces of inferred gold resources and push the Central Tanami Project towards a 2027 development decision.

Kalamazoo Resources has reported standout high-grade gold intersections from its completed drilling at Mt Olympus within the Ashburton Gold Project, reinforcing the deposit’s continuity and growth potential ahead of a resource update.